Creo Medical Group (LSE:CREO) EV-to-EBIT : -2.18 (As of May. 29, 2025)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Creo Medical Group's Enterprise Value is £62.21 Mil. Creo Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was £-28.60 Mil. Therefore, Creo Medical Group's EV-to-EBIT for today is -2.18.

The historical rank and industry rank for Creo Medical Group's EV-to-EBIT or its related term are showing as below:

LSE:CREO' s EV-to-EBIT Range Over the Past 10 Years
Min: -13.57 Med: -3.32 Max: -0.28
Current: -2.17

During the past 10 years, the highest EV-to-EBIT of Creo Medical Group was -0.28. The lowest was -13.57. And the median was -3.32.

LSE:CREO's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 19.425 vs LSE:CREO: -2.17

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Creo Medical Group's Enterprise Value for the quarter that ended in Dec. 2024 was £76.07 Mil. Creo Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was £-28.60 Mil. Creo Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -37.60%.

Creo Medical Group EV-to-EBIT Historical Data

The historical data trend for Creo Medical Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group EV-to-EBIT Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-EBIT

Get a 7-Day Free Trial

-11.75

-7.90

-1.45

-6.47

-2.66

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial														-1.45	-	-6.47	-	-2.66

Competitive Comparison of Creo Medical Group's EV-to-EBIT

For the Medical Devices subindustry, Creo Medical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Creo Medical Group EV-to-EBIT Calculation

Creo Medical Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	62.211	/	-28.6
	=	-2.18

Creo Medical Group's current Enterprise Value is £62.21 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creo Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was £-28.60 Mil.

Creo Medical Group (LSE:CREO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Creo Medical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 )	=	EBIT	/	Enterprise Value (Q: Dec. 2024 )
	=	-28.6	/	76.069055
	=	-37.60 %

Creo Medical Group's Enterprise Value for the quarter that ended in Dec. 2024 was £76.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creo Medical Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was £-28.60 Mil.

Creo Medical Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

CMEOF:USA

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from Europe and the rest from the United Kingdom and the rest of the world.

Creo Medical Group Headlines

No Headlines